News
Needham Reiterates Hold on Amphastar Pharma
9 May 24
News, Reiteration, Analyst Ratings
Amphastar Pharma Q1 2024 Adj EPS $1.04 Beats $0.77 Estimate, Sales $171.800M Miss $174.713M Estimate
8 May 24
Earnings, Earnings Beats, Earnings Misses, News
Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca
1 May 24
Biotech, Large Cap, News, Regulations, Health Care, General
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
10 Apr 24
Analyst Color, Biotech, News, Health Care, Analyst Ratings, Trading Ideas, General
Needham Reiterates Hold on Amphastar Pharma
10 Apr 24
News, Reiteration, Analyst Ratings
JP Morgan Initiates Coverage On Amphastar Pharma with Overweight Rating, Announces Price Target of $60
5 Mar 24
News, Price Target, Initiation, Analyst Ratings
Amphastar Pharma Q4 EPS $0.88 Misses $0.91 Estimate, Sales $178.10M Beat $175.67M Estimate
28 Feb 24
Earnings, News
Earnings Scheduled For February 28, 2024
28 Feb 24
Earnings
Earnings Outlook For Amphastar Pharma
27 Feb 24
Earnings
Press releases
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
9 May 24
Events, Press Releases
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
8 May 24
Earnings, Press Releases
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
28 Feb 24
Earnings, Press Releases
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
20 Feb 24
Earnings, Press Releases